CHEOY
Price
$88.00
Change
-$0.01 (-0.01%)
Updated
Dec 26 closing price
Capitalization
11.48B
Intraday BUY SELL Signals
TRUMY
Price
$14.64
Change
-$0.04 (-0.27%)
Updated
Dec 26 closing price
Capitalization
21.7B
39 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CHEOY vs TRUMY

Header iconCHEOY vs TRUMY Comparison
Open Charts CHEOY vs TRUMYBanner chart's image
CochLear
Price$88.00
Change-$0.01 (-0.01%)
Volume$8.65K
Capitalization11.48B
Terumo
Price$14.64
Change-$0.04 (-0.27%)
Volume$211.55K
Capitalization21.7B
CHEOY vs TRUMY Comparison Chart in %
CHEOY
Daily Signal:
Gain/Loss:
TRUMY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CHEOY vs. TRUMY commentary
Dec 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHEOY is a Hold and TRUMY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 28, 2025
Stock price -- (CHEOY: $88.00 vs. TRUMY: $14.64)
Brand notoriety: CHEOY and TRUMY are both not notable
CHEOY represents the Medical/Nursing Services, while TRUMY is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CHEOY: 61% vs. TRUMY: 86%
Market capitalization -- CHEOY: $11.48B vs. TRUMY: $21.7B
CHEOY [@Medical/Nursing Services] is valued at $11.48B. TRUMY’s [@Pharmaceuticals: Other] market capitalization is $21.7B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $217.08B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $204.83B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.69B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.61B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CHEOY’s FA Score shows that 1 FA rating(s) are green whileTRUMY’s FA Score has 2 green FA rating(s).

  • CHEOY’s FA Score: 1 green, 4 red.
  • TRUMY’s FA Score: 2 green, 3 red.
According to our system of comparison, both CHEOY and TRUMY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CHEOY’s TA Score shows that 4 TA indicator(s) are bullish while TRUMY’s TA Score has 2 bullish TA indicator(s).

  • CHEOY’s TA Score: 4 bullish, 5 bearish.
  • TRUMY’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, CHEOY is a better buy in the short-term than TRUMY.

Price Growth

CHEOY (@Medical/Nursing Services) experienced а +3.29% price change this week, while TRUMY (@Pharmaceuticals: Other) price change was -1.94% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.17%. For the same industry, the average monthly price growth was -1.20%, and the average quarterly price growth was +13.25%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.14%. For the same industry, the average monthly price growth was -3.04%, and the average quarterly price growth was +0.26%.

Reported Earning Dates

TRUMY is expected to report earnings on Feb 05, 2026.

Industries' Descriptions

@Medical/Nursing Services (-0.17% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-1.14% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRUMY($21.7B) has a higher market cap than CHEOY($11.5B). CHEOY has higher P/E ratio than TRUMY: CHEOY (44.19) vs TRUMY (25.82). CHEOY YTD gains are higher at: 0.515 vs. TRUMY (-24.923). TRUMY has higher annual earnings (EBITDA): 260B vs. CHEOY (620M). TRUMY has higher revenues than CHEOY: TRUMY (1.06T) vs CHEOY (2.34B).
CHEOYTRUMYCHEOY / TRUMY
Capitalization11.5B21.7B53%
EBITDA620M260B0%
Gain YTD0.515-24.923-2%
P/E Ratio44.1925.82171%
Revenue2.34B1.06T0%
Total CashN/A217B-
Total DebtN/A160B-
FUNDAMENTALS RATINGS
CHEOY vs TRUMY: Fundamental Ratings
CHEOY
TRUMY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
33
Fair valued
PROFIT vs RISK RATING
1..100
75100
SMR RATING
1..100
4518
PRICE GROWTH RATING
1..100
7380
P/E GROWTH RATING
1..100
7586
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CHEOY's Valuation (15) in the null industry is in the same range as TRUMY (33). This means that CHEOY’s stock grew similarly to TRUMY’s over the last 12 months.

CHEOY's Profit vs Risk Rating (75) in the null industry is in the same range as TRUMY (100). This means that CHEOY’s stock grew similarly to TRUMY’s over the last 12 months.

TRUMY's SMR Rating (18) in the null industry is in the same range as CHEOY (45). This means that TRUMY’s stock grew similarly to CHEOY’s over the last 12 months.

CHEOY's Price Growth Rating (73) in the null industry is in the same range as TRUMY (80). This means that CHEOY’s stock grew similarly to TRUMY’s over the last 12 months.

CHEOY's P/E Growth Rating (75) in the null industry is in the same range as TRUMY (86). This means that CHEOY’s stock grew similarly to TRUMY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CHEOYTRUMY
RSI
ODDS (%)
Bullish Trend 5 days ago
70%
Bullish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
62%
Bearish Trend 3 days ago
66%
Momentum
ODDS (%)
Bearish Trend 3 days ago
56%
Bearish Trend 3 days ago
73%
MACD
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
58%
Bearish Trend 3 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
58%
Bearish Trend 3 days ago
68%
Advances
ODDS (%)
Bullish Trend 5 days ago
63%
N/A
Declines
ODDS (%)
Bearish Trend 12 days ago
62%
Bearish Trend 3 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
78%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
66%
Bearish Trend 3 days ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
CHEOY
Daily Signal:
Gain/Loss:
TRUMY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FPXI60.720.48
+0.80%
First Trust International Eq Opps ETF
INTW41.640.17
+0.41%
GraniteShares 2x Long INTC Daily ETF
DBEU48.150.16
+0.34%
Xtrackers MSCI Europe Hedged Equity ETF
DFIC34.650.03
+0.07%
Dimensional International Core Eq 2 ETF
IFEB30.260.02
+0.06%
Innovator Intl Dev Pwr Bffr ETF - Feb

CHEOY and

Correlation & Price change

A.I.dvisor indicates that over the last year, CHEOY has been loosely correlated with TRUMY. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CHEOY jumps, then TRUMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHEOY
1D Price
Change %
CHEOY100%
-0.01%
TRUMY - CHEOY
34%
Loosely correlated
-0.27%
TWST - CHEOY
32%
Poorly correlated
-1.58%
HOCPY - CHEOY
30%
Poorly correlated
-0.16%
SKHHY - CHEOY
28%
Poorly correlated
+0.86%
ICLR - CHEOY
28%
Poorly correlated
-0.46%
More

TRUMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRUMY has been loosely correlated with HOCPY. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TRUMY jumps, then HOCPY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRUMY
1D Price
Change %
TRUMY100%
-0.27%
HOCPY - TRUMY
51%
Loosely correlated
-0.16%
SSMXY - TRUMY
45%
Loosely correlated
-1.01%
SMTI - TRUMY
43%
Loosely correlated
-1.22%
OLYMY - TRUMY
40%
Loosely correlated
+0.20%
AZTA - TRUMY
39%
Loosely correlated
+0.70%
More